# Find Bio-Tech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/find-bio-tech

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.findbiotech.cn
- Total disclosed funding: $14M
- Latest round: Series B (Sep 25, 2015)
- Investors on record: 3

## About

Find Bio-Tech is a biotechnology firm focused on developing innovative solutions for healthcare and agriculture, addressing critical challenges in health and environmental sustainability through advanced technologies.Founded in 2012, Find Bio-Tech is based in Shanghai, China, and specializes in the development of therapeutics and agricultural biotechnology. The company has been involved in three deals, with the most recent being a TRADE SALE on February 24, 2017, where Sanpower Group acquired Find Bio-Tech for RMB 680 million. No details on founders or previous companies are available.Find Bio-Tech focuses on the development and commercialization of innovative biotechnological products that address critical challenges in healthcare and environmental sustainability. Their core offerings include advanced therapeutics for various diseases, leveraging genomic and proteomic technologies to enhance patient outcomes. Additionally, the company provides tailored solutions for agricultural biotechnology, aimed at improving crop resilience and yield, thereby meeting the demand for sustainable farming practices. Find Bio-Tech serves diverse clients, including healthcare providers, pharmaceutical companies, and agricultural organizations primarily in North America, Europe, and select markets in Asia.Find Bio-Tech generates revenue through a combination of direct-to-consumer sales and B2B partnerships with healthcare institutions and agricultural firms. The company’s flagship products are offered under structured pricing plans tailored to different client segments. Transactions typically involve long-term contracts with healthcare providers for therapeutics, while agricultural products are sold through established distribution networks to wholesalers and retailers. Clients engage with Find Bio-Tech through subscription models for ongoing access to proprietary technologies and updates on product developments, showcasing the company’s diversified revenue streams.Find Bio-Tech plans to expand its product offerings with several new therapeutics and agricultural solutions expected to launch by the end of 2024. The company is targeting expansion into markets in South America and Southeast Asia, aiming for initial market entry by mid-2025. The recent acquisition by Sanpower Group for RMB 680 million will support these initiatives, providing resources for research and development to further enhance their product lineup.

## Funding rounds

- Series B, Sep 25, 2015, $14M — GF Xinde Investment, By-Health
- Series A, Jun 1, 2013 — Oriental Fortune Capital

## Investors

- Oriental Fortune Capital (https://capitalatlas.ai/funds/oriental-fortune-capital) — Series A
- GF Xinde Investment (https://capitalatlas.ai/funds/gf-xinde-investment) — Series B
- By-Health — Series B